GKOS

GLAUKOS Corp

Surgical & Medical Instruments & Apparatus · SIC 3841CIK 1192448Held by 7 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

Revenue FY2025

$507.0M

Net Income FY2025

$(188.0M)

EPS (Basic, as reported)

$-3.28

Net Margin FY2025

-37.0%

ROE FY2025

-28.6%

Total Equity

$656.0M

Shares Out

59M

Business description

GLAUKOS Corp — Surgical & Medical Instruments & Apparatus. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2013–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions

default rows · click any row to chart itRevenue: 114 → 507 +18% CAGR

Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025

Revenue114159181237225294283315383507

Cost of revenue(16)(21)(25)(39)(92)(67)(69)(76)(94)(112)

Gross profit98138156198133227214239289283

Research & development(29)(39)(50)———————

Selling, general & administrative(65)(96)(120)(177)(171)(179)(193)(224)(261)(332)

Total operating expenses(94)(140)(169)(249)(257)(260)(296)(368)(412)(482)

Operating income4(2)(13)(50)(124)(33)(82)(129)(122)(200)

Interest expense———(3)(14)(13)(14)(14)(10)(5)

Interest & investment income——————————

Other income (expense), net0210(9)(16)(16)(5)(23)7

Pre-tax income50(12)(50)(132)(49)(98)(134)(146)(193)

Income tax expense00(1)(65)(12)0(1)(1)(1)(5)

Net income50(13)15(120)(50)(99)(135)(146)(188)

EPS — basic$0.14$0.00($0.37)$0.41($2.70)($1.07)($2.09)($2.78)($2.77)($3.28)

EPS — diluted$0.12$0.00($0.37)$0.37($2.70)($1.07)($2.09)($2.78)($2.77)($3.28)

Shares outstanding — basic (M)33343537444647485357

Shares outstanding — diluted (M)36343541444647485357

Showing the latest 10 of 13 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.